XML 30 R28.htm IDEA: XBRL DOCUMENT

INTANGIBLE ASSETS (Tables)

6 Months Ended

Jun. 30, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of intangible assets

The following table sets forth the gross carrying amount and accumulated amortization of our intangible assets as of June 30, 2014 and December 31, 2013:

		June 30, 2014
		Gross Carrying Amount				Accumulated Amortization				Net Amount				Weighted- Average Remaining Amortization Period (yrs.)
Amortizing intangible assets:

OPERA® software patent		$	31,951			$	(1,498	)		$	30,453				15.25

Development costs of corporate website			91,743				(91,743	)			—				n/a

Approved hormone therapy drug candidate patents			387,806				(8,489	)			379,317				18.75

Non-amortizing intangible assets:

Hormone therapy drug candidate patents (pending)			381,369				—				381,369				n/a

Multiple trademarks for vitamins/supplements			75,968				—				75,968				n/a
Total		$	968,837			$	(101,730	)		$	867,107

		December 31, 2013
		Gross Carrying Amount				Accumulated Amortization				Net Amount				Weighted- Average Remaining Amortization Period (yrs.)
Amortizing intangible assets:

OPERA® software patent		$	31,951			$	(499	)		$	31,452				15.8

Development costs of corporate website			91,743				(89,661	)			2,082				0.3

Non-amortizing intangible assets:

Hormone therapy drug candidate patents (pending)			572,726				—				572,726				n/a

Multiple trademarks for vitamins/supplements			59,328				—				59,328				n/a
Total		$	755,748			$	(90,160	)		$	665,588

Schedule of estimated amortization expense

Estimated amortization expense for the next five years is as follows:

Year Ending December 31,		Estimated Amortization
2014 (6 months)		$	11,250
2015		$	22,500
2016		$	22,500
2017		$	22,500
2018		$	22,500